NEW YORK (GenomeWeb News) - Accelrys yesterday reported a 2 percent increase in fiscal fourth-quarter revenues as R&D spending fell 22 percent and the company cut its quarterly loss by 84 percent.
 
Total receipts for the three months ended March 31, 2007, increased to $19.9 million from $19.4 million year over year.
 
Accelrys said growth in its SciTegic Pipeline Pilot product line was offset by reduced sales of legacy products that were “deemphasized" due to product line restructuring.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.